I agree that this site is using cookies. You can find further informations here.
X
Naehrlich, L.
78  results:
OpenAccess-fulltext X
Search for persons X
?
1

Data accuracy, consistency and completeness of the national..:

Wolf, L ; Usemann, J ; Collaud, E...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jcf.2023.08.015.  , 2024
Link: https://serval.unil.ch/n..
 
?
2

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment red..:

Mainz, J.G ; Zagoya, C ; Polte, L...
https://eprints.whiterose.ac.uk/206814/1/Corrigendum%20Elexacaftor-Tezacaftor-Ivacaftor%20treatment%20reduces%20abdominal%20symptoms%20in%20cystic%20fibrosis-early%20results%20obtained%20with%20the%20CF-specific%20CFAbd-Score.pdf.  , 2023
Link: https://eprints.whiteros..
 
?
3

Incidence of SARS-CoV-2 and risk factors for severe outcome..:

Orenti A ; Dunlevy F ; Zolin A...
info:eu-repo/semantics/altIdentifier/isbn/9791280503244.  , 2022
Link: https://hdl.handle.net/2..
 
?
4

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdomina..:

Mainz, JG ; Zagoya, C ; Polte, L...
https://eprints.whiterose.ac.uk/188023/6/fphar-13-877118.pdf.  , 2022
Link: https://eprints.whiteros..
 
?
5

Incidence of SARS-CoV-2 in people with cystic fibrosis in E..:

Naehrlich L ; Orenti A ; Dunlevy F...
info:eu-repo/semantics/altIdentifier/pmid/34016559.  , 2021
Link: http://hdl.handle.net/24..
 
?
6

Impact of COVID-19 on people with cystic fibrosis:

Colombo C ; Burgel P. R ; Gartner S...
info:eu-repo/semantics/altIdentifier/pmid/32304639.  , 2020
Link: http://hdl.handle.net/24..
 
?
7

Altered relaxation times in MRI indicate bronchopulmonary d..:

Förster, K ; Ertl-Wagner, B ; Ehrhardt, H...
info:eu-repo/semantics/altIdentifier/doi/10.1136/thoraxjnl-2018-212384.  , 2020
Link: https://push-zb.helmholt..
 
?
8

The European Cystic Fibrosis Society Patient Registry's Dat..:

Van Rens J ; Fox A ; Krasnyk M...
European Conference on Rare Diseases and Orphan Products.  , 2020
Link: http://hdl.handle.net/24..
 
?
9

The European Cystic Fibrosis Society Patient Registry (ECFS..:

Naehrlich, L ; Fox, A ; Krasynk, M...
ECFS European Cystic Fibrosis Conference: June, 5th - 8th.  , 2019
Link: http://hdl.handle.net/24..
 
?
10

Epidemiology of European adults with Cystic Fibrosis:

Zolin A ; Naehrlich L ; Fox A...
Adult Cystic Fibrosis International Workshop : 5 - 6 September.  , 2019
Link: http://hdl.handle.net/24..
 
?
11

Hermansky-Pudlak syndrome type 2 manifests with fibrosing l..:

Hengst, M ; Naehrlich, L ; Mahavadi, P...
https://pure.eur.nl/en/publications/8e8519fa-6eb5-4f55-95b3-97607b6b1b4b.  , 2018
Link: https://pure.eur.nl/en/p..
 
?
12

Hermansky-Pudlak syndrome type 2 manifests with fibrosing l..:

Hengst, M ; Naehrlich, L ; Mahavadi, P...
Hengst , M , Naehrlich , L , Mahavadi , P , Grosse-Onnebrink , J , Lagro , S , Skanke , LH , Schuch , LA , Brasch , F , Guenther , A , Reu , S , Ley-Zaporozhan , J & Griese , M 2018 , ' Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood ' , Orphanet Journal of Rare Diseases , vol. 13 , 42 . https://doi.org/10.1186/s13023-018-0780-z.  , 2018
Link: https://pure.eur.nl/en/p..
 
?
13

A protocol for emulating a published randomised controlled ..:

Granger, Emily ; Todd, Jonathan ; Charman, Susan...
https://researchonline.lshtm.ac.uk/id/eprint/4673143/1/Granger_etal_2024_a-protocol-for-emulating-a-published.pdf.  , 2024
Link: https://researchonline.l..
 
?
14

Effectiveness of lumacaftor/ivacaftor initiation in childre..:

Kim, Claire ; Higgins, Mark ; Liu, Lingyun...
info:eu-repo/semantics/altIdentifier/pmid/38402082.  , 2024
Link: https://hdl.handle.net/2..
 
?
15

Cystic fibrosis in Europe: improved lung function & longevi..:

Kerem, Eitan ; Orenti, Annalisa ; Adamoli, Arianna...
info:eu-repo/semantics/altIdentifier/pmid/38302155.  , 2024
Link: https://hdl.handle.net/2..
 
1-15